27/04/22

Twin contracts a validation of Opyl’s pivot to AI and the success of its flagship platform, Opin

“Our track record of recruitment success to date and word of mouth is driving increased interest in the Opin platform with global and local biopharma, medtech and researchers,” said Opyl CEO, Michelle Gallaher, in a Stockhead article.